We investigated the effects of interferon therapy on hepatocyte human leukocyte antigen class I and class I1 antigen expression and intrahepatic lymphocyte subsets in patients with chronic viral hepatitis B (n = 11) and C (n = 10). Interferon-a was administered intramuscularly in doses ranging from
Effects of recombinant leukocyte interferon on serum immunoglobulin concentrations and lymphocyte subpopulations in chronic hepatitis B
β Scribed by Hiroshi Tsuji; Koichiro Murai; Kimihiro Akagi; Masatoshi Fujishima
- Publisher
- Springer
- Year
- 1990
- Tongue
- English
- Weight
- 768 KB
- Volume
- 10
- Category
- Article
- ISSN
- 0271-9142
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Twenty patients with HBeAg-positive chronic liver disease were given large doses of recombinant leukocyte interferon for 4 weeks. Changes of hepatitis B virus DNA in livers and sera were analyzed by the molecular hybridization technique in paired biopsies obtained before and 2 weeks after treatment.
et al. ( 12), or may decrease production of viral proteins.
In a randomized controlled trial of recombinant a-2a interferon for chronic hepatitis B, interferon antibodies developed in 21 (39%) of 54 Chinese adults who received IFN. No correlation was observed between sex, age, pretreatment serum ALT level or liver histological findings and the development of
We investigated the efficacy of a short course of prednisone therapy in 20 patients with histologic evidence of chronic active hepatitis B. Sixteen of 20 prednisonetreated patients who were initially serum hepatitis B virus DNA-positive had a transient elevation of their serum ALT activity on withdr